MedPath

UNIVERSITY OF CALIFORNIA SAN FRANCISCO

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Five Years Later: COVID-19's Lasting Impact on Oncology Care and Research

The COVID-19 pandemic has fundamentally transformed oncology care delivery, with telemedicine emerging as a permanent fixture that improves access while presenting challenges in patient assessment and reimbursement.

CROI 2025 to Showcase Breakthrough Research in HIV, COVID-19, and Viral Infections

The Conference on Retroviruses and Opportunistic Infections (CROI) 2025 will convene in San Francisco from March 9-12, featuring cutting-edge research on HIV cure strategies, COVID-19 variants, and viral infections.

Rural Pharmacists Face Mounting Challenges: Expert Highlights Critical Workforce and Safety Concerns

Rural pharmacists are experiencing severe burnout due to multiple roles across community, hospital, and long-term care settings, significantly impacting healthcare delivery in underserved areas.

Multiple Sclerosis Research Update: Advances in Understanding and Treatment

Genetic risk factors for MS were traced back to migrations 5,000 years ago, offering insights into disease origins.

Seltorexant Shows Promise as First-in-Class Treatment for Depression with Insomnia in Phase III Trial

Phase III trial demonstrates seltorexant's efficacy as an add-on therapy, showing significant improvement in depression scores with a -2.6 point difference on the MADRS scale compared to placebo.

Metabolic Profiling at Birth Shows Promise in Identifying Infants at Risk of SIDS

A recent case-control study links abnormal newborn metabolic profiles with an increased risk of Sudden Infant Death Syndrome (SIDS).

© Copyright 2025. All Rights Reserved by MedPath